| Date | Title | Description |
| 08.10.2018 | Durham-based Spyryx Raises $5.9M from Seven Investors | Biotechnology company Spyryx Biosciences raised $5.9 million to fund its working capital and compensate its executive officers, according to a filing with the Securities and Exchange Commission on Thursday.
The Durham-based company raised t... |
| 08.10.2018 | Durham-based Spyryx Raises $5.9M from Seven Investors | Biotechnology company Spyryx Biosciences raised $5.9 million to fund its working capital and compensate its executive officers, according to a filing with the Securities and Exchange Commission on Thursday.
The Durham-based company raised t... |
| 13.07.2017 | Durham-based Spyryx Biosciences Raises $5M | A Durham-based biotechnology company has raised $5 million from a debt and options offering, according to a filing with the Securities and Exchange Commission.
Spyryx Biosciences Inc. raised the money from 13 investors, according to the fil... |
| 13.07.2017 | Durham-based Spyryx Biosciences Raises $5M | A Durham-based biotechnology company has raised $5 million from a debt and options offering, according to a filing with the Securities and Exchange Commission.
Spyryx Biosciences Inc. raised the money from 13 investors, according to the fil... |
| 08.05.2015 | Spyryx Biosciences Raises $18M in Series A Funding | Spyryx Biosciences, a Research Triangle Park, North Carolina-based company that develops treatments for respiratory diseases, raised $18m in Series A funding.
Backers included Canaan Partners, Hatteras Venture Partners and 5AM Ventures. In ... |
| 07.05.2015 | Spyryx Biosciences raises $18M with a novel take on cystic fibrosis | Vertex Pharmaceuticals ($VRTX) has made a major difference--and a lot of money--in cystic fibrosis with its targeted treatments, drugs tailored for patients with particular genetic defects. But upstart Spyryx Biosciences believes it may hav... |
| 07.05.2015 | Spyryx Biosciences Secures $18M |
RESEARCH TRIANGLE PARK, N.C., Spyryx Biosciences announced today that it has secured $18 million in Series A venture capital financing.
>> Click here for more funding data on Spyryx Biosciences
>> To export Spyryx Bioscience... |
| 07.05.2015 | SPYRYX BIOSCIENCES SECURES $18 MILLION IN SERIES A FINANCING | - |
